All Rousselots collagen peptides, including Nextida GC, have been developed for and tested in individuals of different ages, ethnicities and life stages across the world
GLP-1 medications can be beneficial for managing Type 2 diabetes and promoting weight loss in some people, but they may not be suitable for everyone
Zepbound before and after results from SURMOUNT trials, with a realistic month-by-month timeline, dose data, and side-effect context
Semaglutide works by enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite through central pathways
Observational studies report a lower incidence of dementia and Parkinsons disease among long-term GLP-1RA users, although causality is not established
Insulin (all types)